DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis
FRA:DRW8 - Deutsche Boerse Ag - DE0005550602 - Common Stock - Currency: EUR
Overall DRW8 gets a fundamental rating of 5 out of 10. We evaluated DRW8 against 60 industry peers in the Health Care Equipment & Supplies industry. DRW8 has an average financial health and profitability rating. DRW8 may be a bit undervalued, certainly considering the very reasonable score on growth This makes DRW8 very considerable for value investing!
1. Profitability
1.1 Basic Checks
DRW8 had positive earnings in the past year.
DRW8 had a positive operating cash flow in the past year.
Of the past 5 years DRW8 4 years were profitable.
DRW8 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
DRW8 has a Return On Assets of 3.77%. This is in the better half of the industry: DRW8 outperforms 67.27% of its industry peers.
The Return On Equity of DRW8 (7.91%) is better than 65.45% of its industry peers.
DRW8's Return On Invested Capital of 7.03% is fine compared to the rest of the industry. DRW8 outperforms 76.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.77% | ||
| ROE | 7.91% | ||
| ROIC | 7.03% |
ROA(3y)1.91%
ROA(5y)2.48%
ROE(3y)4.54%
ROE(5y)6.84%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DRW8 has a Profit Margin (3.39%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of DRW8 has grown nicely.
DRW8 has a Operating Margin (5.46%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of DRW8 has grown nicely.
The Gross Margin of DRW8 (43.51%) is worse than 61.82% of its industry peers.
In the last couple of years the Gross Margin of DRW8 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.46% | ||
| PM (TTM) | 3.39% | ||
| GM | 43.51% |
OM growth 3Y-23.13%
OM growth 5Y16.22%
PM growth 3Y-16.07%
PM growth 5Y27.03%
GM growth 3Y-2.88%
GM growth 5Y0.27%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DRW8 is creating some value.
DRW8 has about the same amout of shares outstanding than it did 1 year ago.
DRW8 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DRW8 is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.50 indicates that DRW8 is not a great score, but indicates only limited risk for bankruptcy at the moment.
DRW8 has a Altman-Z score of 2.50. This is in the better half of the industry: DRW8 outperforms 63.64% of its industry peers.
DRW8 has a debt to FCF ratio of 2.04. This is a good value and a sign of high solvency as DRW8 would need 2.04 years to pay back of all of its debts.
DRW8 has a better Debt to FCF ratio (2.04) than 90.91% of its industry peers.
DRW8 has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DRW8 (0.18) is better than 74.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 2.04 | ||
| Altman-Z | 2.5 |
ROIC/WACC1.15
WACC6.12%
2.3 Liquidity
A Current Ratio of 1.89 indicates that DRW8 should not have too much problems paying its short term obligations.
DRW8's Current ratio of 1.89 is in line compared to the rest of the industry. DRW8 outperforms 56.36% of its industry peers.
A Quick Ratio of 1.10 indicates that DRW8 should not have too much problems paying its short term obligations.
DRW8 has a Quick ratio (1.10) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.89 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 21.04% over the past year.
DRW8 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.41% yearly.
DRW8 shows a small growth in Revenue. In the last year, the Revenue has grown by 0.26%.
DRW8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.39% yearly.
EPS 1Y (TTM)21.04%
EPS 3Y-16.8%
EPS 5Y32.41%
EPS Q2Q%-16.8%
Revenue 1Y (TTM)0.26%
Revenue growth 3Y-0.32%
Revenue growth 5Y5.39%
Sales Q2Q%-1.77%
3.2 Future
DRW8 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.86% yearly.
Based on estimates for the next years, DRW8 will show a small growth in Revenue. The Revenue will grow by 2.42% on average per year.
EPS Next Y17.96%
EPS Next 2Y6.3%
EPS Next 3Y9.53%
EPS Next 5Y5.86%
Revenue Next Year0.67%
Revenue Next 2Y2.28%
Revenue Next 3Y2.9%
Revenue Next 5Y2.42%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.80 indicates a rather cheap valuation of DRW8.
Compared to the rest of the industry, the Price/Earnings ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 98.18% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. DRW8 is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 8.42, the valuation of DRW8 can be described as very reasonable.
Based on the Price/Forward Earnings ratio, DRW8 is valued cheaper than 90.91% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, DRW8 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.8 | ||
| Fwd PE | 8.42 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DRW8 is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than DRW8, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.13 | ||
| EV/EBITDA | 2.85 |
4.3 Compensation for Growth
DRW8's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.43
PEG (5Y)0.24
EPS Next 2Y6.3%
EPS Next 3Y9.53%
5. Dividend
5.1 Amount
DRW8 has a Yearly Dividend Yield of 3.66%.
DRW8's Dividend Yield is rather good when compared to the industry average which is at 2.26. DRW8 pays more dividend than 96.36% of the companies in the same industry.
DRW8's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.66% |
5.2 History
The dividend of DRW8 decreases each year by -20.60%.
Dividend Growth(5Y)-20.6%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
29.23% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
DP29.23%
EPS Next 2Y6.3%
EPS Next 3Y9.53%
FRA:DRW8 (3/7/2025, 7:00:00 PM)
47.2
-0.3 (-0.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners11.4%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap885.47M
Analysts77.33
Price Target62.56 (32.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.66% |
Yearly Dividend0.2
Dividend Growth(5Y)-20.6%
DP29.23%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)15.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-1.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.8 | ||
| Fwd PE | 8.42 | ||
| P/S | 0.26 | ||
| P/FCF | 6.13 | ||
| P/OCF | 4.42 | ||
| P/B | 0.62 | ||
| P/tB | 0.81 | ||
| EV/EBITDA | 2.85 |
EPS(TTM)6.05
EY12.82%
EPS(NY)5.6
Fwd EY11.87%
FCF(TTM)7.7
FCFY16.31%
OCF(TTM)10.67
OCFY22.6%
SpS178.45
BVpS76.45
TBVpS58.2
PEG (NY)0.43
PEG (5Y)0.24
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.77% | ||
| ROE | 7.91% | ||
| ROCE | 8.87% | ||
| ROIC | 7.03% | ||
| ROICexc | 7.85% | ||
| ROICexgc | 9.64% | ||
| OM | 5.46% | ||
| PM (TTM) | 3.39% | ||
| GM | 43.51% | ||
| FCFM | 4.31% |
ROA(3y)1.91%
ROA(5y)2.48%
ROE(3y)4.54%
ROE(5y)6.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-28.72%
ROICexcg growth 5Y17.17%
ROICexc growth 3Y-27.87%
ROICexc growth 5Y18.11%
OM growth 3Y-23.13%
OM growth 5Y16.22%
PM growth 3Y-16.07%
PM growth 5Y27.03%
GM growth 3Y-2.88%
GM growth 5Y0.27%
F-Score8
Asset Turnover1.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 2.04 | ||
| Debt/EBITDA | 0.78 | ||
| Cap/Depr | 38.75% | ||
| Cap/Sales | 1.66% | ||
| Interest Coverage | 8.65 | ||
| Cash Conversion | 61.3% | ||
| Profit Quality | 127.34% | ||
| Current Ratio | 1.89 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 2.5 |
F-Score8
WACC6.12%
ROIC/WACC1.15
Cap/Depr(3y)55.8%
Cap/Depr(5y)60.36%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.04%
EPS 3Y-16.8%
EPS 5Y32.41%
EPS Q2Q%-16.8%
EPS Next Y17.96%
EPS Next 2Y6.3%
EPS Next 3Y9.53%
EPS Next 5Y5.86%
Revenue 1Y (TTM)0.26%
Revenue growth 3Y-0.32%
Revenue growth 5Y5.39%
Sales Q2Q%-1.77%
Revenue Next Year0.67%
Revenue Next 2Y2.28%
Revenue Next 3Y2.9%
Revenue Next 5Y2.42%
EBIT growth 1Y26.95%
EBIT growth 3Y-23.37%
EBIT growth 5Y22.48%
EBIT Next Year99.31%
EBIT Next 3Y30.73%
EBIT Next 5Y14.41%
FCF growth 1Y158.68%
FCF growth 3Y-29.12%
FCF growth 5YN/A
OCF growth 1Y224.65%
OCF growth 3Y-25.57%
OCF growth 5Y115.41%